Neximmune Inc (NEXI)

Finanzdaten der Neximmune Inc-Aktie (NEXI)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	48.63% 2.7575	5.3678	9.9958	7.7847	9.8254
Operating Income/Loss	48.63% -2.7575	-5.3678	-9.9958	-7.7847	-9.8254
Nonoperating Income/Loss	3,591% -0.3198	0.00916	0.1416	0.2182	0.2603
Income/Loss From Continuing Operations Before Tax	720.05% -3.0773	-0.3753	-9.8542	-7.5665	-9.5651
Income Tax Expense/Benefit	100.00% -	4.9834	-	-	-
Income/Loss From Continuing Operations After Tax	42.57% -3.0773	-5.3586	-9.8542	-7.5665	-9.5651
Net Income/Loss	42.57% -3.0773	-5.3586	-9.8542	-7.5665	-9.5651
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	26,310% 1.2505	0.00474	1.0479	26.08	26.08
Diluted Average Shares	26,310% 1.2505	0.00474	1.0479	26.08	26.08
Basic Earnings Per Share	50.70% -2.46	-4.99	-9.40	-0.29	-0.37
Diluted Earnings Per Share	50.70% -2.46	-4.99	-9.40	-0.29	-0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-